Bristol-Myers Squibb team completes fundraising ride across Europe

2019 C2C4C riders arrive at Bristol-Myers Squibb office in London, UK on 27 Sept. 2019
27 September 2019

The fourth edition of the European Country 2 Country 4 Cancer (C2C4C) ride - which started on 9 September in Munich – came to an end with riders crossing the finish line at the Bristol-Myers Squibb (BMS) London office in Uxbridge.

Six teams with BMS employees from 15 countries covered the impressive distance of 3,600 km cycling across Europe from Germany, through Switzerland, Italy, France and Spain, with the last team crossing the finish line in the U.K. on 26 September.

“This is an extraordinary achievement”, said Dr Cary Adams, CEO of the Union for International Cancer Control. “I can speak on behalf of our members and the cancer patients who will ultimately benefit from this support when I say that we are extremely thankful for this unique fundraising initiative and the continuous trust that BMS has in our work.”

Over USD 130,000 have been raised so far while online donations can still be made until the 31st of October. The money will help UICC members in delivering diverse programs to reduce the cancer burden in their respective countries, to conduct cancer research and to improve the quality of patients’ lives.

Show your support and encourage your colleagues, friends and family to do the same by donating here.

Last update: 
Monday 30 September 2019